欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/0732/001
药品名称Bendamustin Koanaa 2.5 mg/ml powder for concentrate for solution for infusion
活性成分
    • bendamustine hypochloride 2.5 mg/ml
剂型Powder for concentrate for solution for infusion
上市许可持有人Koanaa Healthcare Spain, S.L. Camí De Can Camps 17-19 Piso 2 H Sant Cugat Del Vallès 08174 Barcelona Spain
参考成员国 - 产品名称Austria (AT)
Bendamustin Koanaa 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
许可日期2019/02/25
最近更新日期2023/10/05
药物ATC编码
    • L01AA09 bendamustine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase